IBB vs SCHV
iShares Biotechnology ETF vs Schwab US Large-Cap Value ETF
- • SCHV has the lower expense ratio at 0.04% vs 0.44% for IBB.
- • SCHV pays a higher dividend yield (1.81%).
Side-by-side metrics
| Metric | IBB | SCHV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.04% |
Dividend yield Trailing 12-month yield. | 0.16% | 1.81% |
AUM Assets under management — bigger funds are typically more liquid. | $11.50B | $15.68B |
YTD return | 30.22% | 18.70% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.60 | 0.73 |
P/E ratio | 25.48 | 20.43 |
Last price | $217.75 | $34.95 |
Inception | — | — |
Issuer | iShares | Schwab |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
SCHV top holdings
| BRK-B | Berkshire Hathaway Inc Class B | 3.32% |
| JPM | JPMorgan Chase & Co | 2.95% |
| XOM | ExxonMobil Holdings Corp | 2.53% |
| JNJ | Johnson & Johnson | 2.16% |
| WMT | Walmart Inc | 1.81% |
| ABBV | AbbVie Inc | 1.71% |
| CVX | Chevron Corp | 1.53% |
| CSCO | Cisco Systems Inc | 1.35% |
| PG | Procter & Gamble Co | 1.23% |
| MRK | Merck & Co Inc | 1.21% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About SCHV
SCHV (Schwab US Large-Cap Value ETF) is Large-cap US value at low cost. Managed by Schwab, the fund carries $15.7B in assets under management, an expense ratio of 0.04%, a dividend yield of 1.81%. Its largest holding is Berkshire Hathaway Inc Class B (BRK-B), which represents 3.3% of the portfolio. Real Estate is the fund's largest sector exposure at 4.0%.